aescuvest international GmbH
Ansprechpartner: Frank Schwarz
Tel.: +49 69 25474 1644
Business news for the stock market

aescuvest international GmbH: #TakeBackControl - Aescuvest Supports the Fight Against the Spread of Covid-19

Call to innovators - crowdfunding platform enables broader and more rapid private participation

Aescuvest offers short-track-campaign (c: Aescuvest GmbH)

Frankfurt am Main (pta/22.03.2020/10:05 UTC+1) The Coronavirus is spreading rapidly. To fight this global threat, we have to act now. Everyone can make a contribution - and so will Aescuvest.

Covid-19 not only threatens our health, but also our economy. It is therefore encouraging to see how quickly governments are responding through numerous initiatives that have been launched to mitigate the economic impact, and to promote and fund innovations that may help contain the epidemic.

"We all know that we are a facing an enormous challenge and that public funds are not unlimited. Private sector initiatives are therefore required, and Aescuvest will make its own contribution," said Aescuvest CEO and co-founder Dr. Patrick Pfeffer. "We offer all start-ups and research companies associated with Covid-19 a unique opportunity: We realize a crowdfunding campaign in the shortest possible time." As a platform for innovation in the healthcare and life sciences sector, Aescuvest enables start-ups that are engaged in research or product and solutions development related to combating the Covid-19 pandemic, to quickly launch a fund raising campaign that can help accelerate market entry. In this way, start-ups can access funds much faster than through normal channels. Moreover, through its deep network in the European healthcare sector, Aescuvest is able to help companies quickly gain access to regional, national and EU-wide grants and subsidies.

People can make an active contribution
"At the same time, private individuals are looking for ways to contribute beyond practicing social isolation. Aescuvest provides such an opportunity, whereby people can support companies looking to tackle this challenge head on", Patrick Pfeffer added. "In order to overcome the Coronavirus, we cannot waste time. By providing a quick route to a financial injection, we can help make these products and solutions available to everyone as rapidly as possible", added Patrick Pfeffer. "We will not profit from making our platform available to companies and investors, but rather will use our reach and influence to help accelerate the fight against this global threat."


Who can apply, what criteria does a company need to meet?

* European start-ups, founders and research companies with initiatives related to COVID-19

How much money can a company raise through Aescuvest?

* From EUR 100,000 to EUR 6 million through a subordinated loan

How does the funding work?

* Start-ups can apply online through:
* Aescuvest's independent investment committee will only consider those proposals it deems promising
* With the support of Aescuvest, the start-up will create a project site and submit its offer for approval to the German financial regulator
* The first funds can be made available within two weeks of achieving the EUR100,000 funding threshold

How much does a campaign cost?

* Aescuvest charges a commission that only covers the costs of running the campaign

Who can participate in the funding?

* Everyone, from private individuals to companies and institutions
* In order to be able to act quickly and for legal reasons, promotion of the campaigns will initially be focused on Germany

Companies can submit their application via email to: or online via:

aescuvest is the first pan-European crowdfunding platform exclusively dedicated to the health sector, a dynamic market that is large in size, shows sustained growth rates and is driven by innovation. The platform offers retail investors, business angels and venture capitalists opportunities to make entrepreneurial investments in a promising market with above average returns. For start-up companies it serves as an independent launch pad to finance and market smart ideas, with the potential to directly target up to 550,000 healthcare professionals as well as general public all over Europe. Based in the financial hub of Frankfurt, was started as a platform for crowdfunding campaigns for Germany in 2015, bringing innovations in MedTech, Biotech, Health Service and Digital Health to life. In 2018, the start of marked the premier of the first platform to offer cross-border equity crowdfunding for healthcare companies and investors all over Europe:

EIT Health is a network of best-in-class health innovators with approximately 150 partners and is supported by the European Institute of Innovation and Technology (EIT), a body of the European Union. We collaborate across borders to deliver new solutions that can enable European citizens to live longer, healthier lives. As Europeans tackle the challenge of increasing chronic diseases and multi-morbidity, and seek to realise the opportunities that technology offers to move beyond conventional approaches to treatment, prevention and healthy lifestyles, we need thought leaders, innovators and efficient ways to bring innovative healthcare solutions to market. EIT Health addresses these needs. We connect all relevant healthcare players across European borders - making sure to include all sides of the "knowledge triangle", so that innovation can happen at the intersection of research, education and business for the benefit of citizens. For more information visit:


Emitter: aescuvest international GmbH
Hanauer Landstraße 328-330
60314 Frankfurt am Main
Contact Person: Frank Schwarz
Phone: +49 69 25474 1644
ISIN(s): DE000A2PN2F4 (Genussrecht)
Stock Exchange(s): -